Healthcare - Medical - Devices - NYSE - US
$ 138.44
-0.13 %
$ 7.63 B
Market Cap
-47.41
P/E
CASH FLOW STATEMENT
-57.8 M
OPERATING CASH FLOW
14.1 M
INVESTING CASH FLOW
15 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Glaukos Corporation
| Net Income | -135 M |
| Depreciation & Amortization | 38 M |
| Capital Expenditures | -20.2 M |
| Stock-Based Compensation | 43.5 M |
| Change in Working Capital | -10.1 M |
| Others | -4.48 M |
| Free Cash Flow | -78 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (134.7) | (99.2) | (49.6) | (120.3) | 15.4 | (13.0) | 92 K | 4.5 | (38.3) | (14.1) | (14.2) | (19.3) |
| Depreciation & Amortization | 38.0 | 35.9 | 34.4 | 34.6 | 9.9 | 6.3 | 5.5 | 4.7 | 4.3 | 4.2 | 1.2 | 0.6 |
| Deferred Income Tax | (0.1) | 54 K | (1.0) | (12.2) | (66.3) | 1.5 | (0.9) | 0.6 | 27.1 | 5 K | (0.2) | 0 |
| Stock Based Compensation | 43.5 | 38.6 | 30.1 | 46.5 | 36.4 | 25.7 | 17.6 | 8.8 | 7.9 | 1.5 | 1.3 | 1.0 |
| Other Operating Activities | 5.7 | 5.1 | 7.2 | 31.7 | 8.7 | 1.9 | 0.7 | 31 K | 0.3 | 33 K | 24 K | (1.8) |
| Change in Working Capital | (10.1) | (13.4) | 3.6 | (3.2) | (4.5) | (3.6) | 2.7 | (6.3) | (3.4) | 1.2 | (1.4) | (1.1) |
| Cash From Operations | (57.8) | (33.1) | 24.7 | (23.0) | (0.4) | 18.9 | 25.5 | 12.3 | (2.2) | (7.1) | (13.3) | (20.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (20.2) | (30.3) | (47.8) | (6.9) | (4.7) | (10.3) | (6.3) | (6.3) | (0.9) | (0.9) | (0.9) | (0.5) |
| Other Items | 34.3 | 75.0 | (10.4) | (198.1) | 48.1 | (16.1) | (5.4) | (19.8) | (84.8) | 0 | (0.1) | 6.6 |
| Cash From Investing Activities | 14.1 | 44.8 | (58.2) | (205.1) | 43.4 | (26.4) | (11.7) | (26.1) | (85.6) | (0.9) | (1.0) | 6.1 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | (3.3) | (2.7) | (3.7) | (3.9) | (5.6) | (0.6) | 0 | 0 | 0 | 0 | (0.1) | 0 |
| Total Debt Repaid | (0.7) | (0.5) | (0.7) | 287.5 | (22.5) | 0 | 0 | (9.7) | (8.0) | 1.9 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 15.8 | 6.8 | 39.9 | (25.0) | 12.9 | 21.6 | 4.7 | 8.1 | 115.1 | 1.6 | 19.4 | 10.5 |
| Cash From Financing Activities | 15.0 | 6.3 | 39.3 | 262.5 | (9.6) | 21.6 | 4.7 | (1.6) | 107.1 | 3.5 | 19.3 | 10.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (27.3) | 16.5 | 4.0 | 34.4 | 33.2 | 14.1 | 18.0 | (15.1) | 19.3 | (4.4) | 5.0 | (3.9) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (78.0) | (63.3) | (23.1) | (29.9) | (5.1) | 8.5 | 19.2 | 6.0 | (3.1) | (8.0) | (14.2) | (21.0) |